Generate QR code
Open Access
Subscription Access
PANCREATIC CANCER: REVIEW AND CLINICAL CASE
https://doi.org/10.48612/agmu/2022.17.3.84.91
Abstract
In the above clinical observation, a patient was found to have stage 4 pancreatic head cancer with metastases to the lungs, kidneys, large omentum, peritoneum, and adrenal gland. A feature of this clinical case is a rare histotype of the tumor: lowgrade adenocarcinoma. A concomitant disease is a transferred new coronavirus infection COVID-19. The article briefly discusses the pathogenesis, risk factors for the development and treatment of inoperable pancreatic cancer. The purpose of this work is to analyze a clinical case of lowgrade pancreatic adenocarcinoma
About the Authors
S. S. Yashin
Samara State Medical University
Russian Federation
Russian Federation
M. V. Melikdzhanyan
Samara State Medical University
Russian Federation
Russian Federation
E. V. Semenaya
Samara State Medical University
Russian Federation
Russian Federation
G. N. Kozlov
Samara State Medical University
Russian Federation
Russian Federation
E. A. Kraynikova
Samara State Medical University
Russian Federation
Russian Federation
References
1. Niger M., Prisciandaro M., Antista M., Monica M., Cattaneo L., Prinzi N., Manglaviti S., Nichetti F., Brambilla M., Torchio M., Corti F., Pusceddu S., Coppa J., Mazzaferro V., de Braud F., Di Bartolomeo M. One size does not fit all for pancreatic cancers: A review on rare histologies and therapeutic approaches // World journal of gastrointestinal oncology. 2020. Vol. 12, no. 8. P. 833-849.
2. Puckett Y., Garfield K. Pancreatic Cancer. URL: https://pubmed.ncbi.nlm.nih.gov/30085538.
3. Каприн А. Д., Старинский В. В., Петрова Г. В. Злокачественные новообразования в России в 2018 году (заболеваемость и смертность). М.: МНИОИ им. П.А. Герцена - филиал ФГБУ «НМИЦ радиологии» Минздрава России; 2019. 250 с.
4. Франциянц Е. М., Кит О. И., Алейнов В. И., Горошинская И. А. Биомаркеры, неоангиогенез и факторы роста при раке поджелудочной железы // Исследования и практика в медицине. 2019. Т. 6, № 3. С. 51-64.
5. Goggins M., Overbeek K. A., Brand R., Syngal S., Del Chiaro M., Bartsch D. K., Bassi C., Carrato A., Far-rell J., Fishman E. K., Fockens P., Gress T. M., van Hooft J. E., Hruban R. H., Kastrinos F., Klein A., Lennon A. M., Lucas A., Park W., Rustgi A., Simeone D., Stoffel E., Vasen H., Cahen D. L., Canto M. I., Bruno M. Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium // Gut. 2020. Vol. 69, no. 1. P. 7-17.
6. Pereira S. P., Oldfield L., Ney A., Hart P. A., Keane M.G., Pandol S. J., Li D., Greenhalf W., Jeon C. Y., Koay E. J., Almario C. V., Halloran C., Lennon A. M., Costello E. Early detection of pancreatic cancer // Lancet Gastroenterol Hepatol. 2020. Vol. 5, no. 7. P. 698-710.
7. Canto M. I., Almario J. A., Schulick R. D., Yeo C. J., Klein A., Blackford A., Shin E. J., Sanyal A., Yenokyan G., Lennon A. M., Kamel I. R., Fishman E. K., Wolfgang C., Weiss M., Hruban R. H., Goggins M. Risk of neoplastic progression in individuals at high risk for pancreatic cancer undergoing long-term surveillance // Gastroenterology. 2018. Vol. 155, no. 3. P. 740-751. e2. 90
8. Yousaf M. N., Chaudhary F. S., Ehsan A., Suarez A. L., Muniraj T., Jamidar P., Aslanian H. R., Farrell J. J. Endoscopic ultrasound (EUS) and the management of pancreatic cancer // BMJ open gastroenterology. 2020. Vol. 7, no. 1. P. e408.
9. Fischer C. G., Wood L. D. From somatic mutation to early detection: insights from molecular characterization of pancreatic cancer precursor lesions // The Journal of pathology. 2018. Vol. 246, no. 4. P. 395-404.
10. Григорьева И. Н., Ефимова О. В. Факторы риска панкреатита и рака поджелудочной железы // Терапевтический архив. 2021. Т. 93, № 8. С. 876-882.
11. Felsenstein M., Hruban R. H., Wood L. D. New Developments in the Molecular Mechanisms of Pancreatic Tumorigenesis // Advances in anatomic pathology. 2018. Vol. 25, no. 2. P. 131-142.
12. Pancreatic cancer in adults: diagnosis and management NICE Guideline, No. 85 National Guideline Alliance (UK). London: National Institute for Health and Care Excellence (UK); 2018.
13. Han X., Ma L., Gu J., Wang D., Li J., Lou W., Saiyin H., Fu D. Basal microvilli define the metabolic capacity and lethal phenotype of pancreatic cancer // The Journal of pathology. 2021. Vol. 253, no. 3. P. 304-314.
14. Ansari D., Friess H., Bauden M., Samnegård J., Andersson R. Pancreatic cancer: disease dynamics, tumor biology and the role of the microenvironment // Oncotarget. 2018. Vol. 9, no. 5. P. 6644-6651.
15. Pothula S. P., Xu Z., Goldstein D., Pirola R. C., Wilson J. S., Apte M. V. Targeting HGF/c-MET Axis in Pancreatic Cancer // International journal of molecular sciences. 2020. Vol. 21, no. 23. P. 9170.
16. Martin C. E., List K. Cell surfaceanchored serine proteases in cancer progression and metastasis // Cancer metastasis reviews. 2019. Vol. 38, no. 3. P. 357-387.
17. Ren, B., Cui, M., Yang, G., Wang, H., Feng, M., You, L., Zhao, Y. Tumor microenvironment participates in metastasis of pancreatic cancer // Molecular cancer. 2018. Vol. 17, no. 1. P. 108.
18. Wagner R., Eckstein S. S., Yamazaki H., Gerst F., Machann J., Jaghutriz B. A., Schürmann A., Solimena M., Singer S., Königsrainer A., Birkenfeld A. L., Häring H. U., Fritsche A., Ullrich S., Heni M. Metabolic implications of pancreatic fat accumulation //Nature reviews. Endocrinology. 2022. Vol. 18, no. 1. P. 43-54.
Review
For citations:
Yashin S.S., Melikdzhanyan M.V., Semenaya E.V., Kozlov G.N., Kraynikova E.A. PANCREATIC CANCER: REVIEW AND CLINICAL CASE. Astrakhan medical journal. 2022;17(3):84-91. (In Russ.) https://doi.org/10.48612/agmu/2022.17.3.84.91
Views:
272
Email this article 